By Brian Mahoney ( April 24, 2014, 5:55 PM EDT) -- The Arkansas Supreme Court on Thursday declined to reconsider its decision freeing Johnson & Johnson and a subsidiary from a $1.2 billion fine over their marketing of the antipsychotic drug Risperdal, one month after finding that the state wrongly sued the pharmaceutical giant under a law targeting health care facilities....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.